5th ANTIBODY SYMPOSIUM


The 5th Antibody Symposium is full of interesting talks with industry participation and is jointly organised by Chugai Pharmabody Research Pte Ltd, Denka Life Innovation Research Pte Ltd (DLIR), Nanyang Technological University and p53Lab, A*STAR.


Speakers include Dr Ann-Marie CHACKO from Duke-NUS, Dr Andre CHOO from BTI, Scientists from Chugai Pharmabody Research Pte Ltd, Dr Samuel GAN from BII, Prof Oliver HANTSCHEL from EPFL School of Life Sciences, Prof Sir David LANE from p53Lab, A/Prof Julien LESCAR from NTU, Prof Paul MACARY from NUS, Prof OOI Eng Eong from Duke-NUS, Prof Peter PREISER from NTU, Prof Felix REY from Pasteur Institute, Dr Danny SOON from EBC, Dr WANG Cheng-I from SIgN and Prof ZENG Qi from IMCB.

 

Date: 5-6 March 2018 (Monday-Tuesday)
Time: Registration starts at 8:30 a.m.

Venue: Breakthrough & Discovery Theatrette, Level 4, Matrix @ Biopolis


**To register, please scroll down and click on "Registration" below.**

 


Day 1: 5 March 2018, Monday

 

Time

Details

   8.30 – 9.00am

Registration

Session 1

9.00 – 9.10am

Welcome Address by Prof Sir David LANE

9.10 – 9.50am

Keynote speaker: Dr Oliver HANTSCHEL, EPFL School of Life Sciences, Switzerland

Targeting Intracellular Oncoproteins With Monobodies: Towards Next-Generation Protein Therapeutics?

9.50 – 10.20am

Prof ZENG Qi, IMCB, A*STAR

PRL3-zumab, From Research In A*STAR To Clinical Trials in NUHS 

10.20 – 10.35am

Dr Danny SOON, EBC, A*STAR 

The Experimental Biotherapeutics Centre (EBC): Bridging The Biologics Translational Gap in Singapore 

10.35 – 11.00am

Coffee & Tea 

Session 2 

11.00 – 11.30am

A/Prof Julien LESCAR, NTU

On Peptide Ligases And Their Applications

11.30am – 12.00pm

Dr WANG Cheng-I, SIGN, A*STAR

A Novel p53-targeted Antibody For Cancer Therapy 

12.00 – 12.30pm

Prof Peter PREISER, NTU

Is Erythrocyte Invasion In Malaria Parasite Infection A Good Target For Therapeutic Interventions? 

12.30 – 12.45pm

Dr John DANGERFIELD, Austrianova Singapore Pte Ltd

Cell-in-a-Box® Live Cell Encapsulation: A Platform Technology For Delivery Of Therapeutic Antibodies

12.45 – 1.40 pm

Lunch

Session 3

1.40 – 2.10pm

Ms Miho FUNAKI, Chugai Pharmaceutical Co., LTD

Emicizumab; Bispecific Antibody For The Treatment Of Hemophilia A

2.10 – 2.40pm

Dr FENG Shu, Chugai Pharmabody Research Pte Ltd

Long-lasting Neutralization Antibody Generated by Recycling and PI Engineering Technologies

2.40 – 3.10pm

Mr Noriyuki TAKAHASHI, Chugai Pharmabody Research Pte Ltd

Automated And High Throughput Platform For Lead Antibody Identification

3.10 – 3.40pm

Dr Samuel GAN, BII, A*STAR

Antibody Engineering Of Therapeutic Antibody Elements: A Detailed Investigation Into The Various Regions And Their Impact

3.40 – 4.10pm

A/Prof Paul MACARY, Department of Microbiology & Immunology, NUS

Solving The Structural Basis For Alloantibody Recognition Of Asian HLA

4.10 – 5.00pm

Networking session 

 



Day 2: 6 March 2018, Tuesday

 

Time

Details

8.30 – 9.00am

Registration

Session 4

9.00 – 9.40am

Keynote speaker: Prof Felix REY, Institut Pasteur, Paris, France 

Towards Epitope-focused Vaccine Design Approaches Against Dengue And Zika Viruses

 

9.40 – 10.10am

Dr LEUNG Hau Wan, BTI, A*STAR

Anti-Glycosylated CEACAM6-MMAE Antibody-Drug Conjugate For Treatment Of Lung Cancer

10.10 – 10.25am

Dr Arif ANWAR, Sengenics Corporation

Applications Of KREX, A Novel Functional Proteomics Technology For Autoantibody Biomarker Discovery

10.25 – 10.50am

Coffee & Tea

Session 5  

10.50– 11.20am

Prof OOI Eng Eong, Emerging Infectious Diseases, Duke-NUS

Bridging Bench And Bedside For Infectious Disease Therapeutic Translation

11.20 – 11.50am

Prof Sir David LANE, p53Lab, BMSI, A*STAR

Development Of Antibodies To Individual Point Mutations In The P53 Protein: Diagnostic And Therapeutic Implications

11.50am – 12.20pm

Dr Ann-Marie CHACKO, Duke-NUS Medical School

Characterization Of Anti-Frizzled Antibody 89Zr-DFO-18R5 For ImmunoPET Imaging Of Cancer

12.20 – 12.30pm

Summing up by Prof Sir David LANE, p53Lab, BMSI, A*STAR

 

Day 1: 5 March 2018, Monday

 

Time

Details

   8.30 – 9.00am

Registration

Session 1: Chairperson – Prof Sir David LANE, p53Lab, BMSI, A*STAR

9.00 – 9.10am

Welcome Address by Prof Sir David LANE

9.10 – 9.50am

Keynote speaker: Prof Felix REY, Institut Pasteur, Paris, France

Towards Epitope-focused Vaccine Design Approaches Against Dengue And Zika Viruses

9.50 – 10.20am

Prof ZENG Qi, IMCB, A*STAR

PRL3-zumab, From Research In A*STAR To Clinical Trials in NUHS

10.20 – 10.35am

Dr Danny SOON, EBC, A*STAR

The Experimental Biotherapeutics Centre (EBC): Bridging The Biologics Translational Gap in Singapore 

10.35 – 11.00am

Coffee & Tea

Session 2: Chairperson – Prof Felix REY, Institut Pasteur

11.00 – 11.30am

Dr LEUNG Hau Wan, BTI, A*STAR

Anti-Glycosylated CEACAM6-MMAE Antibody-Drug Conjugate For Treatment Of Lung Cancer

11.30am – 12.00pm

Dr WANG Cheng-I, SIGN, A*STAR

A Novel p53-targeted Antibody For Cancer Therapy 

12.00 – 12.30pm

Prof Peter PREISER, NTU

Is Erythrocyte Invasion In Malaria Parasite Infection A Good Target For Therapeutic Interventions? 

12.30 – 12.45pm

Dr John DANGERFIELD, Austrianova Singapore Pte Ltd

Cell-in-a-Box® Live Cell Encapsulation: A Platform Technology For Delivery Of Therapeutic Antibodies

12.45 – 1.40 pm

Lunch

Session 3: Chairperson – Prof Peter PREISER, NTU

1.40 – 2.10pm

Ms Miho FUNAKI, Chugai Pharmaceutical Co., LTD

Emicizumab; Bispecific Antibody For The Treatment Of Hemophilia A

2.10 – 2.40pm

Dr FENG Shu, Chugai Pharmabody Research Pte Ltd

Long-lasting Neutralization Antibody Generated by Recycling and PI Engineering Technologies

2.40 – 3.10pm

Mr Noriyuki TAKAHASHI, Chugai Pharmabody Research Pte Ltd

Automated And High Throughput Platform For Lead Antibody Identification

3.10 – 3.40pm

Dr Samuel GAN, BII, A*STAR

Antibody Engineering Of Therapeutic Antibody Elements: A Detailed Investigation Into The Various Regions And Their Impact

3.40 – 4.10pm

A/Prof Paul MACARY, Department of Microbiology & Immunology, NUS

Solving The Structural Basis For Alloantibody Recognition Of Asian HLA

4.10 – 5.00pm

Networking session 

Contact Info :Ms Koh Pei Wen or Ms Sheila Moh
koh_pei_wen@bmsi.a-star.edu.sg or sheila_moh@bmsi.a-star.edu.sg
Date :05 Mar 2018 - 06 Mar 2018  
Venue :Matrix @ Biopolis
30 Biopolis Street
Breakthrough Theatrette
Level 4
Singapore 138671
Location MAP | Enquiry | Email A Friend | PDA | Outlook | Print | Close This Window
chaussure tn nike Air Jordans ball valve manufacturer nike shoes vibram five fingers juicy couture outlet Replica Purses prada shoes,cheap prada shoes cheap mlb jerseys ghd hair straighteners uk prom dresses nike sb dunk,best dunks vibram five fingers speed puma chaussures hommes coach handbags p90x